Form 4 for LION Lionsgate Studios Corp.
Accepted 2026-09-17 16:52:33 ET · period of report 2026-09-15 · accession 0001796999-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-17 16:52 | 2026-09-15 | LION | Ostolaza Yvette | Dir | A - Grant | $3.20 | +18.8K | 166.6K | +13% | +$60.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-09-15 | A | A | 13,405 | $0.00 | 161,225 | D | — | — | (F1) Annual director equity award. (F2) Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027. |
| 2 | Common | Common Shares | 2026-09-15 | A | A | 5,362 | $11.19 | 166,587 | D | — | — | (F3) Director fees paid in common shares. (F2) Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027. |